Literature DB >> 26713654

S2k guideline on diagnosis and treatment of atopic dermatitis--short version.

Thomas Werfel1, Annice Heratizadeh1, Werner Aberer2, Frank Ahrens3, Matthias Augustin4, Tilo Biedermann5, Thomas Diepgen6, Regina Fölster-Holst7, Uwe Gieler8, Julia Kahle9, Alexander Kapp1, Alexander Nast10, Katja Nemat11, Hagen Ott12, Bernhard Przybilla13, Martin Roecken14, Martin Schlaeger15, Peter Schmid-Grendelmeier16, Jochen Schmitt17, Thomas Schwennesen18, Doris Staab19, Margitta Worm20.   

Abstract

Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral superinfections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www.awmf.org).
© 2015 The Authors | Journal compilation © Blackwell Verlag GmbH, Berlin.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26713654     DOI: 10.1111/ddg.12871

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  18 in total

Review 1.  [Neurodermatitis : Atopy of the skin].

Authors:  R Fölster-Holst
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

Review 2.  [Extemporaneous magistral formulas for the topical treatment of pruritus : Proven and new options].

Authors:  P Staubach; E Weisshaar
Journal:  Hautarzt       Date:  2016-08       Impact factor: 0.751

Review 3.  [New developments in extemporaneous formulations].

Authors:  P Staubach; S Melhorn; A Hünerbein; A Peveling-Oberhag
Journal:  Hautarzt       Date:  2016-10       Impact factor: 0.751

Review 4.  [Topical therapy of the scalp].

Authors:  J Wohlrab; J Michael
Journal:  Hautarzt       Date:  2017-06       Impact factor: 0.751

Review 5.  [Basis for the treatment of eczematous diseases in otorhinolaryngology].

Authors:  R Fölster-Holst; A Sperl; T Albrecht; L Klimek
Journal:  HNO       Date:  2017-10       Impact factor: 1.284

Review 6.  The role of the histamine H4 receptor in atopic dermatitis and psoriasis.

Authors:  Katrin Schaper-Gerhardt; Kristine Rossbach; Eirini Nikolouli; Thomas Werfel; Ralf Gutzmer; Susanne Mommert
Journal:  Br J Pharmacol       Date:  2019-01-02       Impact factor: 8.739

Review 7.  [Epidermal barrier disorders in dermatoses].

Authors:  E Proksch; D Dähnhardt; R Fölster-Holst
Journal:  Hautarzt       Date:  2016-11       Impact factor: 0.751

8.  [Patient education for adults with atopic dermatitis according to the ARNE concept].

Authors:  A Heratizadeh; T Werfel; U Gieler; J Kupfer
Journal:  Hautarzt       Date:  2018-03       Impact factor: 0.751

Review 9.  [Eczematous disorders in adolescents].

Authors:  R Fölster-Holst
Journal:  Hautarzt       Date:  2016-04       Impact factor: 0.751

Review 10.  [Topical therapy for atopic eczema].

Authors:  M Knop; A Gürtler; A Heratizadeh; N Aszodi; Th Werfel; A Wollenberg
Journal:  Hautarzt       Date:  2018-03       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.